• Adding Noninvasive Ventilator to At-home Oxygen Therapy Benefits COPD Patients
  • Galecto’s Inhaled IPF Therapy Candidate Shows Early Promise in Clinical Trial
  • Resokine Protein Key to Regulating Inflammation and Fibrosis in Lung Disease, Study Reports
  • Respiratory Infections Linked to Increased Risk of Heart Attack
  • Genoa Pharmaceuticals Secures $62 Million in Funding to Evaluate Aerodone in IPF Treatment
  • New York Researchers Create Lung-in-a-Dish Model to Study Respiratory Diseases
  • Genomic Classifiers Shown to Improve Diagnosis of Lung Cancer and IPF, Veracyte Says
  • Protectin DX Found to Reverse Fibrotic Process in Mice with Lung Fibrosis
  • Pulmatrix Receives US Patent for PUR0200, an Inhaled Formulation for Lung Diseases
  • Esbriet Lowers Risk of Respiratory-Related Hospitalizations in IPF Patients, Study Finds
  • Recent Merger to Focus on Carbon Monoxide Therapies for Chronic Lung Diseases, Other Conditions
  • Artificially Produced Cells Could Boost Lung Disease Research, Study Says

Pulmonary Fibrosis

Asthma

Bronchiectasis

BRONCHIOLITIS

CHRONIC BRONCHITIS

COPD

 CYSTIC FIBROSIS

EMPHYSEMA

IDIOPATHIC PULMONARY FIBROSIS

LUNG CANCER

PNEUMONIA

PULMONARY HYPERTENSION

SCLERODERMA